Skip to content
Ecamsule
Anthelios, Capital Soleil (ecamsule) is a small molecule pharmaceutical. Ecamsule was first approved as Anthelios sx on 2006-07-21.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
Combinations
Anthelios, Anthelios sx, Capital soleil
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Avobenzone
+
Ecamsule
+
Octocrylene
Tradename
Company
Number
Date
Products
CAPITAL SOLEIL 15L'OréalN-021501 OTC2006-10-02
1 products, RLD, RS
ANTHELIOS SXL'OréalN-021502 OTC2006-07-21
1 products, RLD, RS
Avobenzone
+
Ecamsule
+
Octocrylene
+
Titanium dioxide
Tradename
Company
Number
Date
Products
ANTHELIOS 20L'OréalN-021471 OTC2006-10-05
1 products, RLD, RS
ANTHELIOS 40L'OréalN-022009 OTC2008-03-31
2 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
kiehls dermatologist solutions ultra light daily uv defense sunscreen spf 50 high protection anti-pollution lightweight formula for all skin typesExport only2022-12-29
la roche posay face body anthelios spf 60 melt in milk fast absorbing, velvety finish for all skin types with cell-oc shield xlOTC monograph not final2022-12-29
vichy laboratoires capital soleil 50 daily antiaging face sunscreen broad spectrum spf 50 water resistant 80 minutesOTC monograph not final2022-12-28
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
1 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
AdenomaD000236———1—1
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameECAMSULE
INNecamsule
Description
Ecamsule (USAN, trade name Mexoryl SX, INCI terephthalylidene dicamphor sulfonic acid) is an organic compound which is added to many sunscreens to filter out UVA rays. It is a benzylidene camphor derivative, many of which are known for their excellent photostability.
Classification
Small molecule
Drug classcamphorsulfonic acid derivatives used as UVA sunscreens
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CC1(C)C2CCC1(CS(=O)(=O)O)C(=O)C2=Cc1ccc(C=C2C(=O)C3(CS(=O)(=O)O)CCC2C3(C)C)cc1
Identifiers
PDB—
CAS-ID92761-26-7
RxCUI—
ChEMBL IDCHEMBL3989850
ChEBI ID—
PubChem CID6442003
DrugBankDB09534
UNII IDM94R1PM439 (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 67 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
8 adverse events reported
View more details